Robert M. Strieter, M.D.

Robert M. Strieter, MD

Strieter Consulting
在 virginia.edu 的电子邮件经过验证
被引用次数：103144
Early drug development Immunology Inflammation Fibrosis Angiogenesis
Heinz-Josef Lenz

Heinz-Josef Lenz

University of Southern Califfornia
在 usc.edu 的电子邮件经过验证
被引用次数：86331
GI Oncology Molecular Characterization Early Drug Development colon cancer oncology
David M Hyman

David M Hyman

Loxo Oncology, Eli Lilly
在 loxooncology.com 的电子邮件经过验证
被引用次数：42268
Oncology Precision Medicine Cancer Genomics Developmental Therapeutics Early Drug Development
Alexia Iasonos

Alexia Iasonos

Memorial Sloan Kettering Cancer Center
在 mskcc.org 的电子邮件经过验证
被引用次数：14914
biostatistics clinical trials early drug development
Swaminathan Padmanabhan Iyer

Swaminathan Padmanabhan Iyer

Professor of Medicine, University of Texas MD Anderson Cancer Center
在 mdanderson.org 的电子邮件经过验证
被引用次数：12196
Lymphoma Myeloma Early Drug Development
Glenn J. Hanna, M.D.

Glenn J. Hanna, MD

Associate Professor of Medicine, Harvard Medical School
在 dfci.harvard.edu 的电子邮件经过验证
被引用次数：5281
Head and Neck Oncology Early Drug Development
Raymond P Perez

Raymond P Perez

在 kumc.edu 的电子邮件经过验证
被引用次数：4765
Cancer early drug development phase I
Bashkim Kadriu

Bashkim Kadriu

Executive Director, Translational and Experimental Medicine, Neuroscience at Jazz …
在 jazzpharma.com 的电子邮件经过验证
被引用次数：3290
Mood Disorders Translational Medicine Experimental Therapeutics Early Drug Development and
Paolo Tarantino

Paolo Tarantino

Dana-Farber Cancer Institute, Harvard Medical School
在 dfci.harvard.edu 的电子邮件经过验证
被引用次数：3289
Breast Cancer Early Drug Development HER2 Antibody-Drug Conjugates Immunotherapy
Antonio Marra

Antonio Marra

Memorial Sloan Kettering Cancer Center
在 mskcc.org 的电子邮件经过验证
被引用次数：2620
Oncology Translational Research Breast Cancer Early Drug Development
1 - 10